- Home
- VRRM vs ELVN Comparison
VRRM vs ELVN Comparison
Compare VRRM & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRRM | ELVN |
|---|---|---|
| Founded | 1987 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | VRRM | ELVN |
|---|---|---|
| Price | $14.93 | $43.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $25.90 | ★ $43.40 |
| AVG Volume (30 Days) | ★ 1.7M | 1.7M |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 347.37 | 3.17 |
| EPS | ★ 0.85 | N/A |
| Revenue | ★ $132,969,000.00 | N/A |
| Revenue This Year | $6.84 | N/A |
| Revenue Next Year | $6.88 | N/A |
| P/E Ratio | $17.07 | ★ N/A |
| Revenue Growth | ★ 14.61 | N/A |
| 52 Week Low | $13.84 | $14.79 |
| 52 Week High | $25.83 | $46.31 |
Technical Indicators
Market Signals| Indicator | VRRM | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 46.13 | 70.86 |
| Support Level | $13.84 | $18.04 |
| Resistance Level | $25.25 | N/A |
| Average True Range (ATR) | 0.47 | 2.78 |
| MACD | 0.21 | 0.74 |
| Stochastic Oscillator | 84.94 | 86.13 |
Price Performance
Historical ComparisonAbout VRRM Verra Mobility Corporation
Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe, and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three reportable segments: Commercial Services, Government Solutions, and Parking Solutions. Maximum revenue is generated from the Commercial Services segment, which offers toll and violation management solutions and title and registration services for commercial fleet customers, including RACs and FMCs in North America. In Europe, it provides tolling and violations processing services.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.